FDA Permitting Norepinephrine Injection Imports only by Sandoz
The Food and Drug Administration has issued a letter announcing that Sandoz is coordinating with FDA to increase the availability of the norepinephrine bitartrate injection due to the current critical shortage. FDA states that at this time, no other company…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
except Sandoz is authorized by FDA to import norepinephrine bitartrate injection for distribution. Any sales of imported Norepinephrine from any entity other than Sandoz will be considered in violation of the Federal Food, Drug and Cosmetic Act and may be subject to enforcement action by the FDA.